The clinical role of the treatment for hypersplenism in patients with cirrhosis

Research output: Contribution to journalArticle

Abstract

The spleen has major roles in immunity and blood filtration. Splenomegaly is usually secondary to infection, hematological diseases, or cirrhosis. We can make diagnosis accurately by using ultrasound or computed tomography. Two third of cirrhotic patients have splenomegaly due to portal hypertension; and they often have thrombocytopenia. The cirrhotic patients may need invasive therapy for their diseases, such as dental extractions, percutaneous local ablation for hepatoma, paracentesis for ascites and hydrothorax. These procedures may be hampered by the presence of bleeding tendency. The indication of treatment of splenomegaly in cirrhotic patients is presence of thrombocytopenia or complications from portal hypertension. Current treatment modalities include splenectomy, partial splenic embolization, irradiation, and radiofrequency ablation. The benefits are increased platelet counts, reduced episodes of variceal bleeding and improved liver function. Therefore, treatment for hypersplenism may offer improved life quality and improved survival for these cirrhotic patients.

Original languageEnglish
Pages (from-to)403-408
Number of pages6
JournalJournal of Internal Medicine of Taiwan
Volume20
Issue number5
Publication statusPublished - 2009 Oct

Fingerprint

Hypersplenism
Splenomegaly
Fibrosis
Portal Hypertension
Thrombocytopenia
Hydrothorax
Hemorrhage
Paracentesis
Tooth Extraction
Hematologic Diseases
Splenectomy
Therapeutics
Coinfection
Platelet Count
Ascites
Hepatocellular Carcinoma
Immunity
Spleen
Tomography
Quality of Life

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

@article{857b7201f5ad44d7af59830c0950974f,
title = "The clinical role of the treatment for hypersplenism in patients with cirrhosis",
abstract = "The spleen has major roles in immunity and blood filtration. Splenomegaly is usually secondary to infection, hematological diseases, or cirrhosis. We can make diagnosis accurately by using ultrasound or computed tomography. Two third of cirrhotic patients have splenomegaly due to portal hypertension; and they often have thrombocytopenia. The cirrhotic patients may need invasive therapy for their diseases, such as dental extractions, percutaneous local ablation for hepatoma, paracentesis for ascites and hydrothorax. These procedures may be hampered by the presence of bleeding tendency. The indication of treatment of splenomegaly in cirrhotic patients is presence of thrombocytopenia or complications from portal hypertension. Current treatment modalities include splenectomy, partial splenic embolization, irradiation, and radiofrequency ablation. The benefits are increased platelet counts, reduced episodes of variceal bleeding and improved liver function. Therefore, treatment for hypersplenism may offer improved life quality and improved survival for these cirrhotic patients.",
author = "Chang Shing and Chiung-Yu Chen and Xi-Zhang Lin",
year = "2009",
month = "10",
language = "English",
volume = "20",
pages = "403--408",
journal = "Journal of Internal Medicine of Taiwan",
issn = "1016-7390",
publisher = "Society of Internal Medicine of Taiwan",
number = "5",

}

The clinical role of the treatment for hypersplenism in patients with cirrhosis. / Shing, Chang; Chen, Chiung-Yu; Lin, Xi-Zhang.

In: Journal of Internal Medicine of Taiwan, Vol. 20, No. 5, 10.2009, p. 403-408.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The clinical role of the treatment for hypersplenism in patients with cirrhosis

AU - Shing, Chang

AU - Chen, Chiung-Yu

AU - Lin, Xi-Zhang

PY - 2009/10

Y1 - 2009/10

N2 - The spleen has major roles in immunity and blood filtration. Splenomegaly is usually secondary to infection, hematological diseases, or cirrhosis. We can make diagnosis accurately by using ultrasound or computed tomography. Two third of cirrhotic patients have splenomegaly due to portal hypertension; and they often have thrombocytopenia. The cirrhotic patients may need invasive therapy for their diseases, such as dental extractions, percutaneous local ablation for hepatoma, paracentesis for ascites and hydrothorax. These procedures may be hampered by the presence of bleeding tendency. The indication of treatment of splenomegaly in cirrhotic patients is presence of thrombocytopenia or complications from portal hypertension. Current treatment modalities include splenectomy, partial splenic embolization, irradiation, and radiofrequency ablation. The benefits are increased platelet counts, reduced episodes of variceal bleeding and improved liver function. Therefore, treatment for hypersplenism may offer improved life quality and improved survival for these cirrhotic patients.

AB - The spleen has major roles in immunity and blood filtration. Splenomegaly is usually secondary to infection, hematological diseases, or cirrhosis. We can make diagnosis accurately by using ultrasound or computed tomography. Two third of cirrhotic patients have splenomegaly due to portal hypertension; and they often have thrombocytopenia. The cirrhotic patients may need invasive therapy for their diseases, such as dental extractions, percutaneous local ablation for hepatoma, paracentesis for ascites and hydrothorax. These procedures may be hampered by the presence of bleeding tendency. The indication of treatment of splenomegaly in cirrhotic patients is presence of thrombocytopenia or complications from portal hypertension. Current treatment modalities include splenectomy, partial splenic embolization, irradiation, and radiofrequency ablation. The benefits are increased platelet counts, reduced episodes of variceal bleeding and improved liver function. Therefore, treatment for hypersplenism may offer improved life quality and improved survival for these cirrhotic patients.

UR - http://www.scopus.com/inward/record.url?scp=70350736376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350736376&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 403

EP - 408

JO - Journal of Internal Medicine of Taiwan

JF - Journal of Internal Medicine of Taiwan

SN - 1016-7390

IS - 5

ER -